Projects per year
Personal profile
Fingerprint
Dive into the research topics where Zahra Kayani is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Finished
-
REPTAM: Reprogramming of macrophages toward M1 phenotype through gold nanoparticle and proton exposure
Heuskin, A.-C. (PI), Golli, E. (Researcher), Assaf, N. (Technician) & Kayani, Z. (Researcher)
1/01/21 → 31/12/23
Project: Research
Research output
- 9 Article
-
Photosensitizing Activity of Nanoparticles of Poly (2-amino phenol)/Gold for Intensified Doxorubicin Therapeutic Effect on Melanoma Cancer Cells under Synergism Effect of 808-nm Light
Sattarahmady, N., Kayani, Z., Heli, H., Faghani-Eskandarkolaei, P. & Haghighi, H., Dec 2024, In: Journal of biomedical physics & engineering. 14, 6, p. 547-560 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile19 Downloads (Pure) -
Combating cancer by utilizing noble metallic nanostructures in combination with laser photothermal and X-ray radiotherapy
Kayani, Z., Oct 2021, Journal of Drug Delivery Science and Technology, 65.Research output: Contribution to specialist publication › Article
-
Curcumin-gold-polyethylene glycol nanoparticles as a nanosensitizer for photothermal and sonodynamic therapies: In vitro and animal model studies
Kayani, Z., Mar 2021, Photodiagnosis and Photodynamic Therapy, 33.Research output: Contribution to specialist publication › Article
-
Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met
Kayani, Z., Dec 2021, Scientific Reports, 11, 1.Research output: Contribution to specialist publication › Article
Open Access -
Phenanthrotriazine Derivatives Containing Arylidine Hydrazone Moieties as Novel Potential c-Met Inhibitors with Anticancer Effect
Kayani, Z., Jul 2021, The Iranian Journal of Pharmaceutical Research , 20, 3, p. 516–531 16 p.Research output: Contribution to specialist publication › Article